Fong Cora J, Burgoon Lyle D, Williams Kurt J, Forgacs Agnes L, Zacharewski Timothy R
Department of Biochemistry & Molecular Biology, Michigan State University, East Lansing, MI 48824, USA.
BMC Genomics. 2007 Jun 7;8:151. doi: 10.1186/1471-2164-8-151.
Uterine temporal and dose-dependent histopathologic, morphometric and gene expression responses to the selective estrogen receptor modulator tamoxifen (TAM) were comprehensively examined to further elucidate its estrogen receptor-mediated effects. These results were systematically compared to the effects elicited by the potent estrogen receptor ligand 17alpha-ethynylestradiol (EE) to identify pathways similarly and uniquely modified by each compound.
Three daily doses of 100 microg/kg TAM elicited a dose-dependent increase in uterine wet weight (UWW) in immature, ovariectomized C57BL/6 mice at 72 hrs with concurrent increases in luminal epithelial cell height (LECH), luminal circumference and glandular epithelial tubule number. Significant UWW and LECH increases were detected at 24 hrs after a single dose of 100 microg/kg TAM. cDNA microarray analysis identified 2235 differentially expressed genes following a single dose of 100 microg/kg TAM at 2, 4, 8, 12, 18 and 24 hrs, and at 72 hrs after three daily doses (3 x 24 hrs). Functional annotation of differentially expressed genes was associated with cell growth and proliferation, cytoskeletal organization, extracellular matrix modification, nucleotide synthesis, DNA replication, protein synthesis and turnover, lipid metabolism, glycolysis and immunological responses as is expected from the uterotrophic response. Comparative analysis of TAM and EE treatments identified 1209 common, differentially expressed genes, the majority of which exhibited similar profiles despite a temporal delay in TAM elicited responses. However, several conserved and treatment specific responses were identified that are consistent with proliferation (Fos, Cdkn1a, Anapc1), and water imbibition (Slc30a3, Slc30a5) responses elicited by EE.
Overall, TAM and EE share similar gene expression profiles. However, TAM responses exhibit lower efficacy, while responses unique to EE are consistent with the physiological differences elicited between compounds.
全面研究了子宫对选择性雌激素受体调节剂他莫昔芬(TAM)的时间和剂量依赖性组织病理学、形态计量学及基因表达反应,以进一步阐明其雌激素受体介导的作用。将这些结果与强效雌激素受体配体17α-乙炔雌二醇(EE)所引发的效应进行系统比较,以确定每种化合物相似及独特修饰的途径。
对未成熟、卵巢切除的C57BL/6小鼠每日三次给予100μg/kg TAM,在72小时时子宫湿重(UWW)呈剂量依赖性增加,同时管腔上皮细胞高度(LECH)、管腔周长和腺上皮小管数量增加。单次给予100μg/kg TAM后24小时,检测到UWW和LECH显著增加。cDNA微阵列分析确定了单次给予100μg/kg TAM后2、4、8、12、18和24小时以及每日三次给药(3×24小时)后72小时,有2235个差异表达基因。差异表达基因的功能注释与细胞生长和增殖、细胞骨架组织、细胞外基质修饰、核苷酸合成、DNA复制、蛋白质合成与周转、脂质代谢、糖酵解及免疫反应相关,这与子宫营养反应预期一致。TAM和EE处理的比较分析确定了1209个共同的差异表达基因,尽管TAM引发的反应存在时间延迟,但大多数基因表现出相似的谱型。然而,确定了一些保守的和处理特异性反应,这些反应与EE引发的增殖(Fos、Cdkn1a、Anapc1)和吸水(Slc30a3、Slc30a5)反应一致。
总体而言,TAM和EE具有相似的基因表达谱型。然而,TAM的反应效力较低,而EE独特的反应与化合物之间引发的生理差异一致。